Total Payments
$9,286
2024 Payments
$1,680
Companies
47
Transactions
545
Medicare Patients
1,005
Medicare Billing
$95,939
Payment Breakdown by Category
Food & Beverage$9,256 (99.7%)
Education$29.99 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,256 | 544 | 99.7% |
| Education | $29.99 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,301 | 101 | $0 (2024) |
| PFIZER INC. | $1,051 | 83 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,024 | 42 | $0 (2024) |
| GlaxoSmithKline, LLC. | $845.15 | 54 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $572.72 | 23 | $0 (2023) |
| Lilly USA, LLC | $541.78 | 32 | $0 (2024) |
| Novo Nordisk Inc | $508.66 | 31 | $0 (2024) |
| Abbott Laboratories | $501.80 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $382.39 | 22 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $321.70 | 16 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,680 | 84 | ABBVIE INC. ($420.88) |
| 2023 | $1,176 | 74 | ABBVIE INC. ($340.96) |
| 2022 | $1,019 | 61 | ABBVIE INC. ($212.78) |
| 2021 | $1,548 | 88 | AstraZeneca Pharmaceuticals LP ($314.99) |
| 2020 | $813.14 | 58 | Allergan, Inc. ($145.80) |
| 2019 | $680.45 | 47 | Boehringer Ingelheim Pharmaceuticals, Inc. ($142.78) |
| 2018 | $991.78 | 57 | PFIZER INC. ($298.15) |
| 2017 | $1,378 | 76 | AstraZeneca Pharmaceuticals LP ($286.76) |
All Payment Transactions
545 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/19/2024 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug), CONTRAVE | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/27/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Endocrinology | ||||||
| 11/05/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $100.55 | General |
| Category: Neuromodulation | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Diabetes Care | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.36 | General |
| Category: Cardiovascular | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/08/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $160.06 | General |
| Category: Neuromodulation | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $14.58 | General |
| Category: Insulin Pump | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 161 | 294 | $46,196 | $18,850 |
| 2022 | 4 | 149 | 243 | $39,429 | $15,584 |
| 2021 | 4 | 230 | 343 | $54,903 | $24,725 |
| 2020 | 10 | 465 | 727 | $70,310 | $36,780 |
Total Patients
1,005
Total Services
1,607
Medicare Billing
$95,939
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 179 | $25,060 | $9,729 | 38.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $9,685 | $4,707 | 48.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 48 | $9,888 | $3,705 | 37.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 15 | $1,095 | $585.76 | 53.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 12 | 13 | $468.00 | $123.76 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 146 | $20,440 | $7,877 | 38.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $8,185 | $4,090 | 50.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 50 | $10,300 | $3,489 | 33.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 11 | 14 | $504.00 | $127.91 | 25.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 98 | 193 | $24,545 | $9,907 | 40.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 49 | 49 | $10,250 | $6,282 | 61.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 84 | $15,632 | $5,761 | 36.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 17 | 17 | $4,476 | $2,775 | 62.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 132 | 309 | $26,265 | $13,770 | 52.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 87 | 87 | $10,875 | $9,578 | 88.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 83 | 109 | $14,170 | $5,860 | 41.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 18 | 63 | $9,135 | $2,733 | 29.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 41 | 48 | $4,080 | $1,942 | 47.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 13 | 13 | $2,340 | $1,589 | 67.9% |
| 90756 | Vaccine for influenza for injection into muscle | Office | 2020 | 22 | 22 | $1,100 | $581.70 | 52.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 21 | 21 | $525.00 | $332.43 | 63.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 12 | 12 | $960.00 | $254.39 | 26.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 36 | 43 | $860.00 | $139.64 | 16.2% |
About Dr. David Gboloo, MD
Dr. David Gboloo, MD is a Internal Medicine healthcare provider based in Gonzales, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528163326.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Gboloo, MD has received a total of $9,286 in payments from pharmaceutical and medical device companies, with $1,680 received in 2024. These payments were reported across 545 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($9,256).
As a Medicare-enrolled provider, Gboloo has provided services to 1,005 Medicare beneficiaries, totaling 1,607 services with total Medicare billing of $95,939. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Gonzales, LA
- Active Since 09/14/2006
- Last Updated 05/26/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1528163326
Products in Payments
- VRAYLAR (Drug) $874.81
- TRELEGY ELLIPTA (Drug) $542.15
- UBRELVY (Drug) $451.62
- FARXIGA (Drug) $395.77
- JARDIANCE (Drug) $389.63
- ENTRESTO (Drug) $343.08
- BREZTRI (Drug) $327.61
- LYRICA (Drug) $304.81
- EUCRISA (Drug) $263.00
- VYVANSE (Drug) $233.65
- Ozempic (Drug) $190.02
- ELIQUIS (Drug) $189.30
- MOUNJARO (Drug) $178.31
- FREESTYLE LIBRE 3 (Device) $167.69
- INFINITY (Device) $160.06
- Victoza (Drug) $157.42
- QULIPTA (Drug) $150.96
- BEVESPI AEROSPHERE (Drug) $150.44
- TRULICITY (Drug) $141.81
- TROKENDI XR (Drug) $134.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Gonzales
Niksad Abraham, Md, MD
Internal Medicine — Payments: $40,753
Internal Medicine $40,753
Mr. Bogdan Nowakowski, Md, MD
Internal Medicine — Payments: $12,252
Internal Medicine $12,252
Paul Aguillard, M.d, M.D
Internal Medicine — Payments: $6,427
Internal Medicine $6,427
Mason Rau, Md, MD
Internal Medicine — Payments: $2,263
Internal Medicine $2,263
Dr. Avril-Linda Prempeh, M.d, M.D
Internal Medicine — Payments: $864.27
Internal Medicine $864.27
Dr. Mohammed Saeed, M.d, M.D
Internal Medicine — Payments: $364.14
Internal Medicine $364.14